Received Jun 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 2 | ER2613 | — |
the patient began experiencing difficulty walking; they could no longer stand or walk; stroke; This is a spontaneous report received from a Consumer or other non HCP from medical information team. A female patient received BNT162b2 (BNT162B2), on 16Mar2021 as dose 2, single (Lot number: ER2613) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: BNT162b2 (DOSE 1, SINGLE), administration date: 23Feb2021, for Covid-19 immunization. The following information was reported: CEREBROVASCULAR ACCIDENT (medically significant) with onset Nov2021, outcome "recovered", described as "stroke"; GAIT DISTURBANCE (non-serious), outcome "recovered", described as "the patient began experiencing difficulty walking"; DYSSTASIA (non-serious), outcome "recovered", described as "they could no longer stand or walk". Therapeutic measures were taken as a result of cerebrovascular accident, gait disturbance, dysstasia. Clinical course: Patient experienced a stroke in Nov2021 (Stated afterwards that she doesn't recall the date, but was before getting the Pfizer Covid 19 Shot). After 8 weeks of therapy, made a full recovery, regaining the ability to walk, go up and down stairs, and showing no remaining reactions, whatsoever. Prior to the stroke, the patient received the first dose of the Pfizer COVID-19 vaccine in Feb2021, with no adverse reaction. Approximately a month later (Mar2021), received the second dose. Within a few days of the second shot, the patient began experiencing difficulty walking, which progressed to the point where they could no longer stand or walk. Patient would like to know if those side effects are common or rarely common after the Covid 19 shot. No follow-up attempts are possible.